Doctor profile · Federal record

Dr. Sharon Scherl, M.D.

Dermatology Physician (CMS: Dermatology) · Tenafly, NJ

  • NPI 1770515595
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 38 yrs in practice
  • Female
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
45 Central Ave
Tenafly, NJ 076701741
(201) 568-8400
fax (201) 568-8554

Credentials & registration

NPPES · NUCC
NPI registered
July 2006 — 20 yrs on file
Profile last updated
July 8, 2007
Year of graduation
1988 — 38 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
New Jersey #MA056598

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1770515595. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
11,533
Distinct HCPCS
10
Medicare allowed
$465,205
HCPCS Description Services Patients Avg allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 4,002 19 $2
17003 Destruction of precancer skin growth, 2-14 growths 2,783 351 $8
99213 Established patient office or other outpatient visit, 20-29 minutes 1,429 1,016 $101
99212 Established patient office or other outpatient visit, 10-19 minutes 994 634 $64
17000 Destruction of precancer skin growth, 1 growth 835 456 $65
11102 Biopsy of related skin growth, first growth 656 478 $115
11103 Biopsy of related skin growth, each additional growth 169 111 $59
99203 New patient office or other outpatient visit, 30-44 minutes 140 140 $124
99202 New patient office or other outpatient visit, 15-29 minutes 77 77 $82
17110 Destruction of skin growth, 1-14 growths 71 62 $130

In context: peer comparison

Among 1 peers in Tenafly Dermatology Physician, average services per provider: 480. This provider delivers 24× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$33,224
Transactions
278
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Dermavant Sciences, INC. 55 $29,760.68
Pfizer INC. 48 $510.24
Abbvie INC. 32 $461.66
Janssen Biotech, INC. 26 $405.93
Ucb, INC. 20 $384.80
Sun Pharmaceutical Industries INC. 27 $360.53
Genzyme Corporation 12 $340.92
Lilly USA, LLC 14 $254.69
Arcutis Biotherapeutics, INC. 17 $226.89
Amgen INC. 12 $179.78
E.R. Squibb & Sons, L.L.C. 4 $66.97
Verrica Pharmaceuticals INC. 4 $55.34
Galderma Laboratories, L.P. 3 $52.87
Novartis Pharmaceuticals Corporation 2 $47.06
Incyte Corporation 2 $33.87

By nature of payment

Compensation for Services Other Than Consulting, Including Serving As Faculty or As A Speaker at A Venue Other Than A Continuing Education Program
$28,000
Food and Beverage
$4,757
Travel and Lodging
$326
Education
$141

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,116
Patients
732
Total drug cost
$143,696
Drug Type Claims Patients Total cost
Hydrocortisone Generic 234 170 $3,081
Triamcinolone Acetonide Generic 194 151 $4,366
Ketoconazole Generic 187 111 $4,219
Fluocinonide Generic 94 70 $3,954
Doxycycline Hyclate Generic 65 21 $3,072
Betamethasone Dipropionate Generic 63 47 $2,389
Mometasone Furoate Generic 60 49 $1,268
Minoxidil Generic 43 13 $886
Ammonium Lactate Generic 36 26 $698
Clobetasol Propionate Generic 33 23 $1,465

Frequently asked questions

Auto-generated from federal data
What is Dr. Sharon Scherl's medical specialty?
Dr. Sharon Scherl practices Dermatology Physician in Tenafly, NJ.
Where does Dr. Sharon Scherl practice?
Dr. Sharon Scherl practices at 45 Central Ave, Tenafly, NJ 076701741. Office phone: 2015688400.
What is Dr. Sharon Scherl's NPI?
Dr. Sharon Scherl's National Provider Identifier (NPI) is 1770515595, issued by NPPES.
Does Dr. Sharon Scherl accept Medicare assignment?
Yes. Dr. Sharon Scherl accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sharon Scherl commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.